Lilly rolling out direct-to-employer obesity drug coverage
The Indianapolis-based drugmaker said the coverage would be administered by third-party administrators to provide employers “transparent, flexible cost-sharing options” for their workers.
Daniel Lee
Articles
Encompass Health to build rehabilitation hospital in Fishers
The facility will be the third in Indiana for Encompass Health Corp., the nation’s largest owner and operator of inpatient rehabilitation hospitals.
Butler names Hoosier doctor, military officer as second-in-command
The new executive vice president and provost replaces Brooke Barnett, who left Butler in June to become president of Rollins College in Florida.
Lilly to open Gateway Labs site in Philadelphia
Since the first biotech incubator site opened in 2019, participating startups have collectively raised more than $3 billion.
Roche survey: Many millennial women skipping cervical cancer screenings
Indianapolis-based Roche Diagnostics said while the survey was conducted in Europe, its implications are global and reflect challenges in the United States.
Orthopedic surgeon takes blunt approach to reforming care
Dr. Michael Meneghini waited out a two-year noncompete clause after leaving Indiana University Health before opening the $35 million Indiana Orthopedic Institute early this year.
Franciscan Health to build $60M, 40-bed rehab hospital on south Indy campus
The new facility will include larger patient rooms, advanced therapy gyms and devices such as advanced technology walking aids to help people regain mobility after major injury.
Lilly CEO calls on state to boost power supply as company seeks to build supercomputer
David Ricks, speaking Thursday during a panel at the annual BioCrossroads Life Sciences Summit, also called for Purdue and Indiana universities to upgrade their lab facilities.
Purdue heads clinical trial for new canine cancer treatment
Researchers say the new treatment holds the potential to treat some dogs diagnosed with cancer without turning to more expensive traditional procedures such as radiation, chemotherapy or surgery.
Financially struggling Riverview Health formalizes services agreement with Parkview Health
The strategic consulting agreement with the Fort Wayne-based hospital system comes as the Hamilton County-owned Riverview is recovering from consecutive years of operating losses.
Lilly’s obesity pill, orforglipron, gets FDA fast-track voucher
The announcement comes on the heels of a deal with the Trump administration to expand access to weight-loss drugs and reduce costs for patients on government-funded insurance and those paying out of pocket.
IU Health taps OrthoIndy leader for top strategy role
During John Ryan’s tenure as CEO of OrthIndy, the practice expanded its services and footprint both locally and across Indiana.
Braun, Purdue lead nuclear summit to promote reactors for Indiana
The Global Nuclear Energy Economic Summit at Purdue University got underway Wednesday with several hundred attendees from energy companies, utilities, academia, government and regulatory agencies.
Elanco’s Q3 earnings top Wall Street forecasts as company continues to deal with debt
Despite reporting a loss, the company saw quarterly growth in the double digits and raised its full-year earnings estimate.
Energy startup looks to develop first-in-nation nuclear reactor in Indiana
First American Nuclear, a 40-employee startup currently based in Washington, says its Indiana-based Closed-Fuel Cycle Nuclear Energy Park will be designed to reprocess and reuse spent nuclear fuel on-site.
Eli Lilly to build $3B manufacturing site in Netherlands
The facility is expected to produce oral medications, including Lilly’s highly anticipated GLP-1 pill for weight loss, orforglipron.
IU-Lilly study to explore drugs’ impact on job productivity
Eli Lilly and Co. is funding and participating in an Indiana University study that examines the health outcomes of people on weight loss drugs, including Lilly medications.
Lilly earnings soar on growth of Mounjaro, Zepbound
With quarterly revenue up 54% from a year ago, Eli Lilly raised it guidance for the year, with the company now expecting revenue in the range of $63 billion to $63.5 billion.
IURC approves settlement for Duke to consider selling coal units to 3rd party
Under the agreement, Duke Energy would be able to solicit interest in the existing coal units at its Cayuga Generating Station after two proposed gas units are placed in service in 2029 and 2030.
Lilly expands Zepbound direct-to-patient access through Walmart partnership
Through its LillyDirect pharmacy, Eli Lilly plans to offer steep discounts on single-dose vials of Zepbound by partnering with the nation’s largest retail chain.